News
-
-
-
-
-
-
PRESS RELEASE
Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG
BRAIN Biotech AG announces successful outcomes at the Annual General Meeting 2024, including approval of silent partnership with Hessen. CEO and Chairman express optimism for future growth and targets -
-
PRESS RELEASE
Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials
BRAIN Biotech AG and AMSilk collaborate on protein engineering for performance materials, registering their first patent application. The strategic partnership aims for sustainable bio-based solutions in the textile industry -
-
PRESS RELEASE
BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further growth initiatives
BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for financing of growth initiatives. The bonds have an interest rate of 6.52% p.a. and a maturity date of 5 September 2026
-
Revolutionizing Fire Camps: NUE's Sustainable Power Solutions Shine at USDA Technology & Development Center
-
Save A Train Continues to Innovate with Rail Enrichment
-
Cameron Ashley Building Products Opens Third Location in the Badger State
-
Event Tickets Center is Named Official Secondary Ticketing Reseller Partner for Most Valuable Promotions and the Historic Jake Paul vs. Mike Tyson Fight
-
GRI Bio (NASDAQ: GRI) Participates in Virtual Investor CEO Connect
-
Amendment of the terms and conditions of the bond completed; Bondholders can convert bonds into shares
-
secunet Security Networks AG successfully holds Annual General Meeting – Broad approval for all proposed resolutions
-
TUI AG: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
-
Fuller, Smith & Turner PLC: Transaction in own shares
-
AngloGold Ashanti US$9.0m (A$13.5m) Gold Farm-in Agreement
-
2024 Annual General Meeting: approval of all resolutions submitted to the Meeting
-
PR – ICADE – Success of the cash tender offer for a total amount of €350 million
-
AMOEBA: ORDINARY AND EXTRAORDINARY GENERAL MEETING OF 27 JUNE 2024 - Availability of preliminary documents
-
Availability of preparatory documents for the annual general meeting of June 13, 2024
-
Safran’s 2024 Annual General Meeting